Calypso, Varian combine cancer tech:
This article was originally published in Clinica
Executive Summary
Tumour detection specialist Calypso Medical has announced plans to combine its Calypso 4D Localization System with Varian Medical Systems' treatment planning system and linear accelerators to enhance radiotherapy treatment. The 4D system, which Calypso (Seattle, Washington) claims is the first device to use a non-ionizing approach for target localisation in treatment setup and monitoring during radiation therapy delivery, aims to give clinicians improved patient positioning, motion management and tumour targeting when integrated with Varian's Eclipse and On Board Imager technologies. Integration of the 4D system and Eclipse is expected to begin after the 4D's launch - it received FDA 510(k) clearance for use in prostate therapy only in July 2006.